MICRO THERAPEUTICS, INC. DBA EV3 HYPERGLIDE; CATHETER, INTRAVASCULAR OCCLUDING, TEMPORARY
|
Back to Search Results |
|
Model Number 104-4127 |
Device Problem
Burst Container or Vessel (1074)
|
Patient Problem
No Clinical Signs, Symptoms or Conditions (4582)
|
Event Date 09/30/2022 |
Event Type
malfunction
|
Manufacturer Narrative
|
Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Event Description
|
Medtronic received information that a hyperglide balloon was leaking during setup.Preparing the hyperglide balloon 4x20 as the usage instruction was detected that it was stuck because it was leaking.To continue the surgery was opened another hyperglide balloon 4x15 that was integrated and followed with the surgery as planned.No patient symptoms or complications were reported.
|
|
Event Description
|
Additional information received reported that the guidewire tip advanced out of the catheter tip during inflation (about 2 cm).The balloon leak was at the tip.The contrast ratio was 50/50.The physician did not mold the tip of the guidewire.Three times the balloon inflated and deflated.The injection rate was noted to be slow.A 1 ml syringe was used during balloon inflation/deflation.
|
|
Manufacturer Narrative
|
Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Manufacturer Narrative
|
H3.Product analysis: equipment used: video inspection system (m-81805), ruler (m-83360) camera (panasonic lumix dmc-zs5), in-house 0.010¿ x-pedion guidewire (model: 103-0605-200 lot: 9579794) as found condition: the hyperglide occlusion balloon catheter was returned for analysis within two shipping boxes; within a sealed plastic biohazard pouch and within an opened hyperglide inner pouch.The guidewire used during the event was not returned for analysis.Visual inspection/damage location details: upon visual inspection, no damages were found with the hyperglide hub, body, marker bands or distal tip.No visible damages were found with the balloon subassembly.Testing/analysis: the hyperglide occlusion balloon catheter was flushed, and water exit the distal tip.An in-house x-pedion guidewire was hydrated and then inserted into the hub, throughout the balloon catheter and out the distal end with no issues.The guidewire was extended out the distal tip ~3cm to test for balloon inflation.The balloon was inflated with no issues, no leaks, and no deflation were observed.Conclusion: based on the device analysis and reported information, the customer¿s reports of ¿no/slow inflation during set up¿ and ¿balloon leak at distal gw seal¿ could not be confirmed.There were no damages found with the returned hyperglide balloon catheter that would contribute towards the failure.In addition, inflation attempt using an in-house x-pedion guidewire successfully inflated the balloon catheter with no issues.As the guidewire used during the event was not returned for analysis, any contribution of the guidewire towards the deflation issue could not be confirmed.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Search Alerts/Recalls
|
|
|